Literature DB >> 18043047

Subungual melanoma: a study of 124 cases highlighting features of early lesions, potential pitfalls in diagnosis, and guidelines for histologic reporting.

Kong-Bing Tan1, Marc Moncrieff, John F Thompson, Stanley W McCarthy, Helen M Shaw, Michael J Quinn, Ling-Xi Lawrence Li, Kerry A Crotty, Jonathan R Stretch, Richard A Scolyer.   

Abstract

Subungual melanoma (SUM) is an uncommon variant of melanoma that is often difficult to diagnose, both clinically and pathologically. In an attempt to provide pathologic clues to diagnosis, especially in early lesions or small biopsies, and to provide practical advice to pathologists in reporting, the clinicopathologic features of 124 cases of SUM were reviewed, the largest series reported to date. The features of 28 cases of subungual melanoma in situ (MIS), comprising 4 cases of MIS and 24 cases where areas of MIS were present adjacent to dermal-invasive SUMs, were compared with those of a similar number of acral nevi to identify useful distinguishing features. The median age of the patients was 59 years and the most common site was the great toe (24%). Nine percent of cases were AJCC stage 0, 14% were stage I, 41% were stage II, 32% were stage III, and 4% were stage IV at initial diagnosis. The commonest histogenetic subtype was acral lentiginous (66%), followed by nodular (25%) and desmoplastic (7%). The majority of tumors were locally advanced at presentation with 79% being Clark level IV or V. The median Breslow thickness was 3.2 mm. The median mitotic rate was 3 per mm and 33% of cases demonstrated primary tumor ulceration. Seven of 29 patients (24%) who underwent a sentinel lymph node biopsy had nodal disease. Multivariate Cox-regression analysis showed higher disease stage to be the only significant predictor of shortened survival. In comparison to acral nevi, MIS more frequently showed lack of circumscription, a prominent lentiginous growth pattern, predominance of single cells over nests, moderate-to-severe cytologic atypia, a dense and haphazard pagetoid intraepidermal spread of melanocytes, and the presence of junctional/subjunctional lymphocytes ("tumor infiltrating lymphocytes"). Tumor infiltrating lymphocytes have not been highlighted previously as a feature of subungual MIS and represent a useful diagnostic clue. Guidelines for the reporting of SUMs are also presented. Knowledge and recognition of the pathologic features of SUMs and the important features that distinguish them from nevi should reduce the frequency of misdiagnosis.

Entities:  

Mesh:

Year:  2007        PMID: 18043047     DOI: 10.1097/PAS.0b013e318073c600

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

1.  Delayed Reconstruction for the Non-Amputative Treatment of Subungual Melanoma.

Authors:  Byung Ho Oh; Hong Sun Jang; Jungsoo Lee; Min Ju Choi; Kyoung Ae Nam; Kee Yang Chung
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

Review 2.  Rare presentations of primary melanoma and special populations: a systematic review.

Authors:  Lisa A Kottschade; Travis E Grotz; Roxana S Dronca; Diva R Salomao; Jose S Pulido; Nabil Wasif; James W Jakub; Sanjay P Bagaria; Riten Kumar; Judith S Kaur; Shane Y Morita; Steven L Moran; Jesse T Nguyen; Emily C Nguyen; Jennifer L Hand; Lori A Erickson; Jerry D Brewer; Christian L Baum; Robert C Miller; David L Swanson; Val Lowe; Svetomir N Markovic
Journal:  Am J Clin Oncol       Date:  2014-12       Impact factor: 2.339

Review 3.  Improving the diagnosis and treatment of acral melanocytic lesions.

Authors:  Maressa C Criscito; Jennifer A Stein
Journal:  Melanoma Manag       Date:  2017-05-19

4.  Subungual malignant melanoma--re-learning the lesson.

Authors:  Kavit Amin; Katy Edmonds; Andrew Fleming; Barry Powell
Journal:  BMJ Case Rep       Date:  2011-03-10

5.  The efficacy of anti-PD-1 agents in acral and mucosal melanoma.

Authors:  Alexander N Shoushtari; Rodrigo R Munhoz; Deborah Kuk; Patrick A Ott; Douglas B Johnson; Katy K Tsai; Suthee Rapisuwon; Zeynep Eroglu; Ryan J Sullivan; Jason J Luke; Tara C Gangadhar; April K S Salama; Varina Clark; Clare Burias; Igor Puzanov; Michael B Atkins; Alain P Algazi; Antoni Ribas; Jedd D Wolchok; Michael A Postow
Journal:  Cancer       Date:  2016-08-17       Impact factor: 6.860

6.  In Vivo Reflectance Confocal Microscopy for the Diagnosis of Melanoma and Melanotic Macules of the Lip.

Authors:  Pablo Uribe; Helena Collgros; Richard A Scolyer; Scott W Menzies; Pascale Guitera
Journal:  JAMA Dermatol       Date:  2017-09-01       Impact factor: 10.282

7.  Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?

Authors:  Priyanka V Gumaste; Nathaniel H Fleming; Ines Silva; Richard L Shapiro; Russell S Berman; Judy Zhong; Iman Osman; Jennifer A Stein
Journal:  J Natl Compr Canc Netw       Date:  2014-12       Impact factor: 11.908

Review 8.  Guidelines of the Brazilian Dermatology Society for diagnosis, treatment and follow up of primary cutaneous melanoma--Part I.

Authors:  Luiz Guilherme Martins Castro; Maria Cristina Messina; Walter Loureiro; Ricardo Silvestre Macarenco; João Pedreira Duprat Neto; Thais Helena Bello Di Giacomo; Flávia Vasques Bittencourt; Renato Marchiori Bakos; Sérgio Schrader Serpa; Hamilton Ometto Stolf; Gabriel Gontijo
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

9.  Missed opportunity to diagnose subungual melanoma: potential pitfalls!

Authors:  Louise Dunphy; Rossell Morhij; Yash Verma; Andrew Pay
Journal:  BMJ Case Rep       Date:  2017-11-03

10.  Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.

Authors:  C A Castaneda; C Torres-Cabala; M Castillo; V Villegas; S Casavilca; L Cano; J Sanchez; J Dunstan; G Calderon; M De La Cruz; J M Cotrina; H L Gomez; R Galvez; J Abugattas
Journal:  Clin Transl Oncol       Date:  2017-06-02       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.